Fresenius Medical Care

Summary

In 1996 was created Fresenius Medical Care, which is appeared as Corporate Investor. The venture was found in Europe in Germany. The main department of described Corporate Investor is located in the Homburg.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Fresenius Medical Care, startups are often financed by Zohar Gilon, California Institute for Regenerative Medicine, Amplify.LA. The meaningful sponsors for the fund in investment in the same round are Mitsubishi UFJ Capital, Grey Sky Venture Partners, ehuda Zisafe. In the next rounds fund is usually obtained by Pangaea Ventures, National Institutes of Health, Mitsubishi UFJ Capital.

The high activity for fund was in 2018. This Fresenius Medical Care works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from Fresenius Medical Care is 500 millions - 1 billion dollars.

This organization was formed by Eduard Fresenius. The overall number of key employees were 25.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Corvidia, Tridiuum, Vectorious Medical Technologies Among the most successful fund investment fields, there are Genetics, Therapeutics. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups.